Search by Drug Name or NDC

    NDC 42847-0106-50 Silenor 6 mg/1 Details

    Silenor 6 mg/1

    Silenor is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Currax Pharmaceuticals LLC. The primary component is DOXEPIN HYDROCHLORIDE.

    Product Information

    NDC 42847-0106
    Product ID 42847-106_1a9b50b3-afcb-4b7b-a891-5fd1da5709c8
    Associated GPIs 60400030100330
    GCN Sequence Number 066592
    GCN Sequence Number Description doxepin HCl TABLET 6 MG ORAL
    HIC3 H2E
    HIC3 Description SEDATIVE-HYPNOTICS,NON-BARBITURATE
    GCN 28915
    HICL Sequence Number 001650
    HICL Sequence Number Description DOXEPIN HCL
    Brand/Generic Brand
    Proprietary Name Silenor
    Proprietary Name Suffix n/a
    Non-Proprietary Name doxepin hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 6
    Active Ingredient Units mg/1
    Substance Name DOXEPIN HYDROCHLORIDE
    Labeler Name Currax Pharmaceuticals LLC
    Pharmaceutical Class Tricyclic Antidepressant [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022036
    Listing Certified Through 2024-12-31

    Package

    NDC 42847-0106-50 (42847010650)

    NDC Package Code 42847-106-50
    Billing NDC 42847010650
    Package 500 TABLET in 1 BOTTLE (42847-106-50)
    Marketing Start Date 2010-08-01
    NDC Exclude Flag N
    Pricing Information N/A